Advanced Manufacturing Growth Investors & VC Firms
796 firms in this list, with a median first check of $3M. 213 of them lead rounds. Generated from verified public data and updated continuously.
Afreximbank
CairoGrowth
52 people
Olympus Partners
StamfordGrowth$75M – $500M
27 people
Heartwood
NorwalkGrowth
31 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$320K – $3.8M
14 people
AUCTUS Capital Partners
MünchenGrowth
43 people
First Reserve Corporation
HoustonGrowth–Late Stage
43 people
Procuritas
StockholmGrowth
32 people
Woven Capital
TokyoSeed–Growth$10M – $50M
36 people
The Westly Group
Menlo ParkPre-Seed–Growth$500K – $15M
22 people
Baillie Gifford
EdinburghSeries B–Late Stage
15 people
Seneca Partners
HaydockSeed–Growth
12 people
Boathouse Capital
BerwynGrowth$5M – $50M
20 people
Abac Capital Manager S.G.E.I.C.,
BarcelonaGrowth
31 people
Advance Venture Partners
San FranciscoSeries A–Growth$10M – $25M
12 people
UOB Venture Management
SingaporeSeed–Growth$10M – $50M
30 people
BGH Capital
MelbourneGrowth
47 people
Blue Sea Capital
West Palm BeachGrowth
38 people
McNally Capital
ChicagoGrowth$15M – $65M
35 people
Aavishkaar Venture Management Services Private Limited
MumbaiSeed–Growth$5M – $25M
23 people
LFM Capital, LLC
NashvilleGrowth
35 people
Momenta Ventures
LucerneSeed–Growth
23 people
Calera Capital
BostonGrowth–Late Stage$50M – $250M
39 people
Adenia Partners
Port LouisGrowth–Late Stage
32 people
International Finance Corporation
WashingtonSeries A–Late Stage
26 people
Related lists
Growth Investors & VC Firms (4561)Growth Investors & VC Firms in North America (2360)Advanced Manufacturing Investors & VC Firms (2063)Growth Investors & VC Firms in United States (2055)Growth Investors & VC Firms in Europe (1814)Growth Investors & VC Firms in Global (1565)Healthtech Growth Investors & VC Firms (1464)Advanced Manufacturing Seed Investors & VC Firms (1408)Fintech Growth Investors & VC Firms (1400)Growth Investors & VC Firms in Asia-Pacific (1343)
Data sourced from public filings and firms' own websites — see our methodology.












































































































